Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (Pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases

(Pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases

US Patent 8058437 · Granted Nov 15, 2011

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene classifiers and uses thereof in non-melanoma skin cancers2024
Dermatology report document2023
Dermatology report document2023
Methods for diagnosing atopic dermatitis using gene classifiers2023
2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene]2023
Gene classifiers and uses thereof in skin cancers2023
Computer display panel with a graphical user interface for a dermatology report2022
Computer display panel with a graphical user interface for a dermatology report2022
2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene]2021
Alpha-tea salt forms: compositions and uses for treating disease2021
Alpha-TEA salt forms: compositions and uses for treating disease2019
Valomaciclovir polymorphs2016